Introduction: The pain associated with peripheral neuropathy (PN) observed in patients living with HIV/AIDS represents a difficult complication to manage. Participants: A total of 22 participants with a diagnosis of PN were recruited to assess the effects of using night splints on pain and sleep quality. Methods: For 3 weeks, the participants were instructed to use bilateral night splints and given an exercise regimen for 3 additional weeks. Scores from pain and sleep questionnaires were analyzed using repeated measures analysis of variance (ANOVA). Results: The change in pain scores (F(1.16) ¼ 13.41,Z 2 ¼.456, P ¼ .002) and sleep index scores (z ¼ À2.69, P ¼ .004, 1-tailed) was found to be significant following the use of night splints. No difference was found with the use of the exercises. Discussion: The use of night splints in HIV-infected patients with PN represents an additional tool for managing pain and improving sleep.
Background
The Joint United Nations Program on HIV/AIDS (UNAIDS) the number of infected individuals currently living with the HIV and AIDS at 33 million worldwide, with a high concentration of cases located in sub-Saharan African countries. 1 The Centers for Disease Control and Prevention (CDC) in their 2006 statistics report that 1 million individuals are living with HIV in America. 2 At any point in the HIV disease process, 40% to 60% of people living with HIV/AIDS (PLWHA) are reported to experience pain in one or more locations in their bodies. 3 Multiple concomitant stressors further influence the overall perception of pain in this population more so than in any other pain population. [3] [4] [5] The etiology of HIV-related pain involves multiple factors due to the complexity of the HIV disease progression and the inherent variability observed in PLWHA. To date the most commonly reported pain syndromes include painful peripheral sensory neuropathy, pain due to extensive Kaposi's sarcoma, headache, pharyngeal and abdominal pain, arthralgias and myalgias, and some dermatological conditions. [6] [7] [8] The incidence of clinical peripheral neuropathy (PN) in the HIV-infected population is reported to vary between 30% and 60%, with increased prevalence in the later stages of AIDS. 9, 10 Neuropathic symptoms can be perplexing to the individual patient as well as being difficult to successfully manage for the health care professional. 11 The somatosensory symptoms follow a ''stocking-glove'' distribution, with prevalence loci to the lower extremities in this patient population. 11 Most patients report symptoms described as altered sensation at the lower extremities such as ''burning'' sensation, crawling, numbness, itching, tingling, and hypersensitivity to tactile stimuli. 11 Pharmacological treatments for PN have focused on the use of tricyclic antidepressant and anticonvulsant medications such as gabapentin. 11, 12 These pharmacological agents assist in inhibiting the effects of peripheral nerve sensitization that is often present following tissue damage and/or inflammation. 13 Electromyographical studies 14, 15 have associated PN with acquired axonal channelopathies (Na þ ) in inflammatory disease models such as multiple sclerosis. These channelopathies lead to a slow depolarization of structurally damaged axons. Additionally, short-and long-term immobilization have been shown to impact the level of excitability of motor neurons. 16, 17 Thus, at least theoretically, physical and/or chemical agents that reduce the level of peripheral nerve excitability may prove effective in managing PN-related allodonya. Empirical observations reveal a pain pattern in patients having PN consistent with painful bilateral metatarsal head upon palpation and reports of severe bilateral lower leg night cramps. Paradoxically, a sparing of protective sensation in the lower extremities in PLWHA is also seen, even in advanced cases of patients living with AIDS.
Splinting interventions follow the established guidelines outlined in the Guide to Physical Therapy Practice of the American Physical Therapy Association (APTA) for the management of painful neuropathies. 18 In a couple of case studies, Sandoval et al 19 used a bilateral lower extremity splinting application with positive pain reduction results to address the pain and sleep disturbances associated with PN in PLWHA. The use of lower extremity splints in the management of PN in PLWHA and other clinical populations remains unproven and requires more controlled clinical trials to validate it as a nonpharmacological pain management intervention. Therefore, the purpose of this study was to evaluate the effects of bilateral night splinting intervention in the management of pain and sleep disturbances in individuals living with HIV-related PN compared to an active placebo intervention of seated upper extremity exercises. The specific aims of this study were to test the following null hypotheses, all with a statistical level of significance set at .05 or less:
A 3-week application of bilateral lower extremity splints
will reduce the reports of pain in patients diagnosed with HIV-related PN. 2. The participants will report an increase in scores of sleep quality index, indicating improved quality and quantity of sleep following the use of bilateral lower extremity splints. 3. The use of bilateral lower extremity splints will prove more effective in managing PN pain than an active placebo consisting of seated upper extremity exercises.
Methods Participants
A total of 22 PLWHA were recruited and signed an informed consent form to participate in this prospective study from the Thomas Street Clinic Health Center (TSCH), Harris County Hospital District (HCHD), Houston, TX. An a priori power analysis, assuming equal distribution of means and standard deviations in both groups for self-reported pain scores, anticipated a minimum of 10 participants per group to achieve a statistical power of .85. A passive recruitment approach was used by recruiting patients based on postings placed in message boards within TSHC. Around 50 individuals sought and received information about this study from the principal investigator. In all, 28 potential participants sought additional information, and of those, 22 participants were enrolled in this study.
Inclusion/Exclusion Criteria
People living with HIV/AIDS with a clinical diagnosis of symptomatic bilateral lower extremity PN were asked to participate. The participants were on a stable pain management regimen without foreseeable alterations to said regimen. The participants exhibited at least 1 or more of the following clinical symptoms: paresthesia, dysesthesia, or numbness as well as reports of night cramps at the lower extremities. Participants were excluded if they had a clinical diagnosis of significant cardiovascular or pulmonary disease (specifically, myocardial infarction within the past 6 months, angina, or dyspnea at rest), paraplegia, hemiplegia, other major neurological dysfunction, no palpable pedal pulse, diabetes, and pregnancy. Additionally, patients diagnosed with sleep apnea and or using any mechanical devices to assist in normalizing sleep were excluded from this study.
Instrumentation
Splinting. Walkabout splints (Don Joy Orthopedics, Vista, CA) were used in the splinting treatment. The Walkabout splint is a 1-piece injection moulded walking boot fitted with a rocker bottom allowing for ambulation. The participants were instructed in the proper fit of the splints as well as how to don the bilateral lower extremity splints for sleeping a minimum of 6 continuous hours at night (see Appendix A).
Pain Measures. A composite pain score was collected using the self-reported Neuropathic Pain Scale (NPS). The NPS is a self-reported 10-item scale scored from 0 to 100, measuring the severity and quality of symptoms in PN. 20 Galer and Jensen 20 reported that the NPS exhibits both predictive and discriminate validity, as well as being sensitive to the effect of treatments affecting neuropathic pain. Although the authors failed to quantify the level of sensitivity or the scale's reliability, the NPS scale exhibits face validity to measure the construct of pain in the presence of PN. The scores obtained using the NPS were converted into percentages for ease of comparisons in this study (see Appendix B).
Sleep Quality/Quantity. The Pittsburgh Sleep Quality Index (PSQI) is a 10-item questionnaire covering the following 7 components of sleep: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medications, and daytime dysfunctions. The PSQI scale is rated by assigning up to 3 points per sleep component for a maximum score of 21. The PSQI has shown acceptable measures of internal homogeneity (Cronbach a ¼ .83), consistency (testÀretest reliability k ¼ .75), and both face and construct validity. 21 Buysse et al reported that a PSQI global score greater than 5% or 24% (5 of 21) yielded a diagnostic sensitivity of 89.6% and specificity of 86.5% in discriminating between good and poor sleepers. Backhaus et al, in a reliability assessment of the PSQI, reported a mean global score for insomniac patients of 12.5 + 3.8 versus a mean score of 3.3 + 1.8 for the control group while the authors also report a similar internal consistency for the scores and high correlations for a 2-day application and a long-term application of the tool (45-day latency); r ¼ .90 and .86, respectively. 22 The scores obtained using the PSQI were converted into percentages for ease of comparisons in this study (see Appendix C).
Upper Extremity Exercises. Upper extremity exercises were used in this study as an active control intervention. Lower extremity exercises were not included in the exercise arm to prevent introducing a confounding variable. The upper extremity exercise protocol included a 5-minute warm-up on the TRU-kinetics upper cycle (Sugarland, TX) upper extremity bike ergometer and a series of resistive exercises using the Nautilus System (NS-4000, Vancouver, WA) The exercise regimen consisted of the following resisted exercises, all performed at 2 sets of 10 repetitions twice per week: bicep curls, shoulder external rotation, seated shoulder press, seated chest press, and seated pectoralis press (butterflies).
Procedures
All patients who agreed to participate signed a Harris County Hospital District Institutional Review Board (IRB)-approved informed consent. The informed consent was discussed and signed in a private location in the Physical Therapy Department at Thomas Street Health Center. The participants completed the 2 self-report questionnaires: NPS and PSQI. Both the pain and sleep quality index scores were collected 4 times during the study: at the onset of study, at week 3 (end of treatment 1), at week 5 (beginning of treatment 2), and finally at the start of week 8 (end of study).
Using a precoded table, the principal investigators randomly assigned the participants to begin the study in the splinting arm or the seated placebo upper extremity exercise treatment arm of the study. The principal investigator who recruited patients was also in charge of all data collection.
The participants beginning with the bilateral splinting application received and were individually fitted with bilateral lower extremity splints. Those beginning in the upper extremity exercise arm were instructed in the upper extremity protocol, including the use of the upper extremity bike ergometer, seated chest press, seated shoulder press, seated pectoralis press, bicep curls, and shoulder external rotation. On completion of the first 3 weeks in their initially assigned intervention, the participants were instructed to resume normal activities for a 1-week period. This ''washout period'' (week 4 of the study) was implemented to minimize any carryover of intervention effect prior to switching treatment intervention. The participants that began with the bilateral splinting application returned their splints to the principal investigator who labelled and stored them until the end of the study. The splints were returned to the participants in the initial splinting application at the end of the study.
At the beginning of week 5, the participants were assigned to the other treatment intervention for the remaining 3 weeks of the study. The participants switching to the bilateral lower extremity splinting intervention used and kept the splints until the end of the study and beyond.
Statistical Considerations
The statistical data analysis was performed using SPSS version 16.0 (SPSS Inc, Chicago, IL). Descriptive statistics including means, modes, minimum scores, and maximum scores were computed on all variables. Diagnostic tests for assumptions of normality, heteroskedasticity, and sphericity were performed using a residual analysis of the data retained for final analysis. A 2 Â 2 analysis of variance (ANOVA) with repeated measures for pain was conducted for the aggregate pain score obtained, with the NPS between pre-post application of splints and also for pre-post implementation of upper extremity exercise program, whereas a paired Wilcoxon test was used for the nonparametric aggregate sleep quality score obtained with the PSQI.
Results

Descriptive Statistics
Initial intake data was collected on 22 participants, 5 of which had incomplete data for the remainder of the study. Of these 5 participants, 1 participant discontinued due to medical complications, 1 participant had incomplete data, and 3 participants did not return after the initial visit. The 3 participants who did not return had been assigned to begin with the upper extremity exercise intervention. Significant differences were found in the participants in respect to the use of pain medications and time since HIV diagnosis. Participants assigned to begin with the active control were on average using fewer pain medications and had been living with an HIV diagnosis on average for 11.22 years compared to 16.83 years for those who began with the splinting application. The participant characteristics retained for analysis are listed in Table 1 . Student t tests for interval/ratio data and Mann-Whitney U test for nonparametric data were used to analyze the differences in the participants based on the initial track assignment. No extreme values or other significant data variations were identified for either of the dependent variables of pain or sleep quality scores. Compliance with the exercise arm in this study was recorded at 47%. A major weather event forced a temporary closure of the study location for 2 weeks, which compounded the poor attendance in the exercise intervention portion of the study.
The participants in the splinting arm of this study exhibited decreased mean scores for the NPS and PSQI following splint application in either treatment track, whether the lower extremity splints were applied before or after the implementation of the active control treatment of upper extremity exercises. The participants who began with the upper extremity exercise intervention of the study exhibited decreased NPS and PSQI scores between before and after upper extremity exercise implementation to a lesser rate than those assigned to the bilateral lower extremity splinting application. The mean NPS scores remained at lower-than-baseline levels in participants that began in track 1 of the study during the active control intervention, whereas a continued decreased in PSQI scores was observed in these participants. The mean scores obtained for the participants initially assigned to the bilateral lower splint applications,or track 1, are reported in Table 2 and illustrated in Figure 1 . The mean scores obtained for the participants in the active control of upper extremity exercises, or track 2, are reported in Table 3 and illustrated in Figure 2 .
Contrasts of Interest
Differences over time were analyzed using multivariate analysis of variance (MANOVA). The 3 single contrasts of interest repeated measures ANOVA were performed with a Bonferroni-adjusted a for the 3 contrasts of interest. The adjusted level to reach statistical significance was therefore set at .0167 or smaller (.05 of 3). The means and standard deviations for the pain and sleep scores retained for analysis to test the proposed null hypotheses are listed in Table 4 .
A repeated measure ANOVA revealed a statistical significance for the main effect of pain scores after using the bilateral lower extremity splints for 3 weeks with an observed power of .93, F(1.16) ¼ 13.41,Z 2 ¼ .456, P ¼ .002. A paired Wilcoxon test was used to evaluate the contrast comparing the sleep quality scores obtained before and after the bilateral lower extremity splint application. The results of this contrast were found to be statistically significant with an observed statistical power of .81, z ¼ À2.69, P ¼ .004 (1-tailed) . The mean of ranks after the 3-week splint application was 6.50 or 31%, whereas the mean of ranks before was 8.23 or 39%.
The contrast of pain scores after the 3-week application of bilateral lower extremity splints and the 3-week upper extremity exercise program failed to reach a level of statistically significant difference with an observed statistical power of .50, F(1,12) ¼ 4.587, Z 2 ¼ .277, P ¼ .053. No statistically significant difference on pain scores was found between before and after the exercise arm intervention, F(1,14) ¼ .085, Z 2 ¼ .003, P ¼ .775.
Discussion
The participants using the lower extremity splints demonstrated improved scores in pain and sleep quality index following a 3-week application of the bilateral lower extremity splints at night with a moderate treatment effect. A 20% reduction in pain scores and a similar reduction in sleep quality index scores. No significant difference in pain and sleep scores were found following splinting application and exercise application, which in turn, may be associated with the relatively short 1-week ''washout'' period of the low number of participants leading to a high level of variability in the data collected and ultimately to a lower than expected statistical power of .50. Additionally, poor attendance at the exercise sessions and the temporary closure of the data collection site may have influenced these results. Thus, it is conceivable that the effects of the bilateral splint application may be longer lasting than the 1-week washout period anticipated in this study.
The data obtained for the different treatment arms (splinting vs exercise) in this study suggest that a treatment effect is observed when using the bilateral lower extremity splinting as a modality to manage pain and sleep disturbances associated with PN in PLWHA, regardless of the treatment track that the participants were initially randomized to follow. Moreover, it is important to point out that all of the participants in this study were using stable pharmacological agents designed to alleviate the symptoms associated with HIV-related neuropathy. A relationship between pain and quantity and quality of sleep has been identified in both acute and chronic pain populations. 23, 24 Sleep disturbances are observed in the presence of neuropathic pain, leading to somnolence and decreased reports of both quality and quantity of sleep. 25 Roehrs et al, 26 found the presence of a hyperalgesic effect after total sleep deprivation, and reductions in the pain threshold after only 8 hours of sleep loss. Additionally, Stiefel and Stagno 27 reported that pain limits sleep, and reduced sleep increases pain in individuals living with chronic pain conditions. These findings point to a cyclical relationship between pain and sleep, as pain interrupts sleep, the sleep disruption causes an increase in the perception of pain. Thus, improvements in both sleep quantity and quality in patients with painful disorders may prove influential in breaking this vicious cycle and possibly enhancing the patients' overall health and quality of life. Chapman et al 28 found, in their study of sleep in veterans, that the greater the depression, the greater the pain and sleep disturbances the patients reported. In the population of veterans studied, not only did pain severity not predict sleep quality but also sleep quality did not predict pain severity either. These studies indicate that future research should include investigation into the effect of depression on pain and sleep in PLWHA.
The limitations of this study also include and are not limited to the sample of convenience, low number of participants, participant adherence to the recommended wearing/splinting schedule, tolerance to the use of splints at night, and compliance with the recommended exercise regimen. Despite these limitations, the use of bilateral lower extremity splints as a pain-management modality in patients living with HIV/AIDS neuropathy may offer clinicians a noninvasive and effective nonpharmacological alternative intervention.
Additional research is needed to corroborate the results of this study while also investigating the analgesic effect of the splint application in patients that are naive to pain medications, the optimal staging of the splint application (before, after, or jointly with pain medications) and finally the neuromuscular mechanisms in place that may explain this analgesic effect.
Conclusions
The use of night splints may offer HIV providers with an additional nonpharmacological pain management option in patients living with HIV-related PN. The most unpleasant sensation imaginable 10. Lastly, we want you to give us an estimate of the severity of your deep versus surface pain. We want to rate each location of pain separately. We realize that it can be difficult to make these estimates, and most likely it will be a ''best guess'', but please give us your best estimate.
HOW INTENSE IS YOUR DEEP PAIN?   No deep  pain   0  1  2  3  4  5  6  7  8  9  10  The most intense  deep pain sensation  imaginable   HOW INTENSE IS YOUR SURFACE PAIN?   No surface  pain   0  1  2  3  4  5  6  7  8  9  10 The most intense surface pain sensation imaginable
Component 4 Sleep Disturbances
Score question 5b-j for each score: none 0 less than once a week 1 once or twice a week 2 three or more times a week 3 sum score fro 5b though 5j Assign a score as follows: Sum of 5b-j 0 0 1 through 9 1 10 through 18 2 19 through 27 3
Component 5
Use of sleeping Medication none 0 less than once a week 1 once or twice a week 2 three or more times a week 3
Component 6 Daytime Dysfunction
Question #8 none 0 less than once a week 1 once or twice a week 2 three or more times a week 3 Question #9 none 0 less than once a week 1 once or twice a week 2 three or more times a week 3 Sum question #8 and #9 0 0 1 through 2 1 3 through 4 2 5 through 6 3
Component 7
Add component 1 through 7 for a global PSQI score
